Blockchain Registration Transaction Record

GLP-1 and SGLT2 Medications May Lower Stroke Survivors' Risk of Future Heart Attack, Stroke

Preliminary study at the American Heart Association's Scientific Sessions 2024 suggests GLP-1 and SGLT2 medications may reduce the risk of heart attack, second strokes, and death in adults who had an initial stroke.

This news is important as it provides potential hope for stroke survivors in reducing their risk of future cardiovascular events. The findings suggest that these commonly prescribed medications for Type 2 diabetes have additional benefits in lowering the risk of subsequent stroke, heart attack, and death, which could significantly impact stroke survival and improve the quality of life for those who have had a stroke.